Fungal colonisation and fluconazole therapy in acute liver disease

Liver

Volumn 18, Issue 5, 1998, Pages 320-325

  Fisher, Neil C ^a   Cooper, Mike A ^a   Hastings, J G Mark ^a   Mutimer, David J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Candida; Fluconazole; Fungal colonisation; Fungal infection; Fungal resistance

Indexed keywords

FLUCONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; CANDIDIASIS; CLINICAL ARTICLE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; MUCOSA; MYCOLOGY; MYCOSIS;

EID: 0031756674     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00812.x     Document Type: Article

References (16)

1. ROLANDO N, HARVEY F, BRAHM J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12: 1-9.
2. CASTALDO M D, STRATTA R J, WOOD P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149-56.
3. TOLLEMAR J, ERICZON B, HOLMBERG K, ANDERSSON J. The Incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc 1990; 22: 242-4.
4. TOLLEMAR J, HOCKERSTEDT K, ERICZON B, JALANKO H, RINGDEN O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. Transplantation 1995; 59: 45-50.
5. WAJSZCZUK C P, DUMMER J S, HO M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347-53.
6. GOODMAN J L, WINSTON D J, GREENFIELD R A, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-51.
7. KUNG N, FISHER N C, GUNSON B, HASTINGS M, MUTIMER D J. Fluconazole prophylaxis for high-risk liver transplant recipients (letter). Lancet 1995; 345: 1234-5.
8. PERFECT J R. Antifungal prophylaxis: to prevent or not (editorial). Am J Med 1993; 94: 233-4.
9. DENNING D W. Can we prevent azole resistance in fungi? (editorial). Lancet 1995; 346: 454-5.
10. O'GRADY J G, ALEXANDER G J M, HAYLLAR K M, WILLIAMS R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
11. COLLINS L A, SAMORE M H, ROBERTS M S, LUZZATI R, JENKINS R L, LEWIS W D. Risk factors for invasive fungal infections complicating orthotopic liver transplantion. J Infect Dis 1994; 170: 644-52.
12. MOORE C B, LAW D, GANGULI L A, KEANEY M G L, DENNING D W. High prevalence of antifungal resistance in Candida in patients with AIDS. J Antimicrob Chemother 1994; 45: 668.
13. KUSNE S, TORRE-CISNEROS J, MANEZ R, IRISH W, MARTIN M, FUNG J. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992; 166: 1379-83.
14. WEISNER R H, HERMANS P E, RAKELA J, et al. Selective bowel decontamination to decrease gram negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988; 45: 570-4.
15. ROLANDO N, GIMSON A, WADE J, PHILPOTT-HOWARD J, CASEWELL M, WILLIAMS R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
16. ROLANDO N, WADE J J, STANGNU J, et al. Prospective study comparing prophylactic parenteral antimicrobials, with or without enteral decontamination, in acute liver failure. Hepatology 1994; 20:125A